Optas LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
6,227
+1,142
| +22% | +$212K | 0.22% | 58 |
|
|
2025
Q1 | $1.07M | Buy |
5,085
+261
| +5% | +$54.7K | 0.19% | 58 |
|
|
2024
Q4 | $857K | Buy |
4,824
+309
| +7% | +$54.9K | 0.18% | 68 |
|
|
2024
Q3 | $892K | Buy |
4,515
+610
| +16% | +$120K | 0.21% | 71 |
|
|
2024
Q2 | $670K | Buy |
3,905
+323
| +9% | +$55.4K | 0.17% | 71 |
|
|
2024
Q1 | $652K | Buy |
3,582
+355
| +11% | +$64.6K | 0.18% | 75 |
|
|
2023
Q4 | $500K | Sell |
3,227
-1,669
| -34% | -$259K | 0.15% | 87 |
|
|
2023
Q3 | $730K | Buy |
4,896
+563
| +13% | +$83.9K | 0.24% | 65 |
|
|
2023
Q2 | $584K | Sell |
4,333
-445
| -9% | -$60K | 0.2% | 83 |
|
|
2023
Q1 | $761K | Buy |
4,778
+247
| +5% | +$39.4K | 0.27% | 62 |
|
|
2022
Q4 | $732K | Buy |
4,531
+41
| +0.9% | +$6.63K | 0.3% | 54 |
|
|
2022
Q3 | $603K | Buy |
4,490
+168
| +4% | +$22.6K | 0.26% | 62 |
|
|
2022
Q2 | $661K | Buy |
4,322
+1,562
| +57% | +$239K | 0.27% | 57 |
|
|
2022
Q1 | $447K | Buy |
2,760
+81
| +3% | +$13.1K | 0.15% | 90 |
|
|
2021
Q4 | $363K | Buy |
2,679
+107
| +4% | +$14.5K | 0.1% | 111 |
|
|
2021
Q3 | $278K | Sell |
2,572
-43
| -2% | -$4.65K | 0.08% | 118 |
|
|
2021
Q2 | $294K | Buy |
2,615
+43
| +2% | +$4.83K | 0.08% | 115 |
|
|
2021
Q1 | $279K | Hold |
2,572
| – | – | 0.09% | 114 |
|
|
2020
Q4 | $276K | Sell |
2,572
-2,370
| -48% | -$254K | 0.09% | 108 |
|
|
2020
Q3 | $431K | Buy |
4,942
+2,830
| +134% | +$247K | 0.13% | 103 |
|
|
2020
Q2 | $208K | Buy |
+2,112
| New | +$208K | 0.08% | 118 |
|